Kalvista Pharmaceuticals, Inc. · NASDAQ:KALV
Millennium Management LLC reported a 5.90% stake in Kalvista Pharmaceuticals, Inc. (Schedule 13G/A)
Event Dec 23, 2025 · Filed Dec 30, 2025
Millennium Management LLC reported a 5.90% stake in Kalvista Pharmaceuticals, Inc., 2,963,699 shares, as a passive investor on Dec 23, 2025. Filed Dec 30, 2025 (Schedule 13G/A).
- Stake
- 5.90%
- Shares
- 2,963,699
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Integrated Core Strategies (US) LLC | 5.10% | 2,588,344 |
| Millennium Management LLC | 5.90% | 2,963,699 |
| Millennium Group Management LLC | 5.90% | 2,963,699 |
| Israel A. Englander | 5.90% | 2,963,699 |
Source
Related
- Kalvista Pharmaceuticals, Inc.
- Millennium Management LLC
- Kalvista Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Millennium Management LLC · May 1, 2026
- Schedule 13G · Millennium Management LLC · Nov 10, 2025
- Schedule 13G/A · Tang Capital Management LLC · Aug 14, 2026
- Form 4 · Audhya Paul K. · Jun 11, 2026
- Form 4 · Sweeny Nicole · Jun 11, 2026
- Form 4 · Palleiko Benjamin L · Jun 11, 2026
- Form 4 · Yea Christopher · Jun 11, 2026